A 28-year-old woman from Mumbai with newly diagnosed HIV (CD4 150 cells/μL, viral load 150,000 copies/mL) is started on antiretroviral therapy with efavirenz + tenofovir + lamivudine. After 2 weeks, she develops severe headache, confusion, and neck stiffness. CSF analysis shows elevated protein (180 mg/dL), normal glucose (45 mg/dL), and no organisms on Gram stain or AFB. India ink stain is positive. What is the primary mechanism by which her CD4 count predisposes her to this infection?

Explanation

## Clinical Diagnosis: Cryptococcal Meningitis The patient presents with **cryptococcal meningitis (CM)**, confirmed by positive India ink stain in CSF. This is a hallmark opportunistic infection in advanced HIV (CD4 <100 cells/μL). ### Pathophysiology of Cryptococcal Infection in HIV **High-Yield:** Cryptococcus neoformans is an encapsulated yeast that survives intracellularly in macrophages. Its control depends critically on **Th1-mediated immunity**, not CD8+ responses or antibodies. ### The Role of CD4+ T Cells in Cryptococcal Defense **Key Point:** CD4+ Th1 cells produce **interferon-gamma (IFN-γ)**, which activates macrophages to: 1. Upregulate antimicrobial peptides and reactive oxygen species (ROS) 2. Enhance phagolysosomal degradation of intracellular *Cryptococcus* 3. Prevent yeast dissemination from lungs to CNS When CD4 <100 cells/μL: - Th1 response collapses - Macrophages remain unactivated - *Cryptococcus* replicates unchecked in tissue macrophages and CNS - Polysaccharide capsule evades antibody recognition ### Why Other Mechanisms Are Not Primary | Mechanism | Role in Cryptococcal Immunity | Why Not Primary | |-----------|-------------------------------|------------------| | **CD8+ cytotoxicity** | Kills infected cells; minor role | Cryptococcus survives intracellularly; Th1/macrophage activation is the main defense | | **Opsonization (Ig)** | Antibodies bind capsule but cannot kill yeast alone | Cryptococcus is poorly opsonized; antibody-mediated killing requires activated macrophages | | **Complement** | C3b deposition; minor role | Cryptococcus capsule inhibits complement activation; not the primary defense mechanism | **Mnemonic: Th1 = Intracellular Pathogens** — CD4+ Th1 cells (producing IFN-γ) are essential for control of intracellular organisms: *Mycobacterium*, *Listeria*, *Cryptococcus*, *Histoplasma*, *Toxoplasma*. ### Clinical Correlation **Clinical Pearl:** Cryptococcal meningitis in HIV typically presents with: - Insidious headache and fever (not acute meningitis) - CSF with high protein, normal/low glucose, few cells (lymphocytic) - India ink or cryptococcal antigen positive - Occurs at CD4 <100 cells/μL - Requires prolonged antifungal therapy (amphotericin B + flucytosine, then fluconazole) [cite:Harrison 21e Ch 197; Robbins 10e Ch 6]